Pharmaceutical combination and method for treatment of reactive arthritis or bursitis
US7691831B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Mar 29, 2005 |
| Grant date | Apr 6, 2010 |
| Priority date | — |
| Expiry date | Oct 19, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/7076
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treatment for conditions in human beings associated with either or both reactive arthritis or bursitis comprising administering a combination of a member from each of the following groups of medications: (1) synthetic purine nucleoside analog antiviral drugs, (2) antibiotic drugs, and (3) imidazole drugs. Alternate embodiments of the invention include dual combinations of (A) a member of the synthetic purine nucleoside analog group of antiviral drugs and a member of the antibiotic group of drugs, (B) a member of the antibiotic group of drugs and a member of the imidazole family of drugs, and (C) a member of the synthetic purine nucleoside analog group of antiviral drugs and a member of the imidazole group of drugs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.